Compare Redwire Corporation (RDW) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Redwire Corporation vs Repligen Corporation Common Stock — how do they compare? Redwire Corporation trades at $8.46 (market cap $2.29B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: Repligen Corporation Common Stock is far larger — about 4.9× Redwire Corporation's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Redwire Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Redwire Corporation for 18 Days and Repligen Corporation Common Stock for 0 Days on average.
| RDW | RGEN | |
|---|---|---|
Market Cap | $2.29B | $11.14B |
Volume | 9,800,070 | 1,259,263 |
Sector | Industrials | Health |
52-Week High | $25.90 | $194.57 |
52-Week Low | $5.06 | $102.87 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | $1.82B | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Redwire Corporation (RDW) trades at $9.16, down 0.65% on the day, showing bearish technical signals despite recent contract wins. The company reported strong revenue growth with Q2 2026 showing 89.6% year-over-year increase, but continues to post significant losses with a net income margin of -57.26%. Recent developments include a $981 million Space Force contract award and partnerships with Honda and Sophia Space for orbital infrastructure projects.
While analyst consensus remains bullish with an 80% buy rating and $14.88 price target, the stock faces substantial execution risks amid persistent losses and negative cash flow from operations. The company's growth trajectory depends heavily on successful contract execution and SpaceX's Starship development, making this a high-risk, high-potential investment in the emerging space economy.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
